Latest News and Press Releases
Want to stay updated on the latest news?
-
GEVORKYAN, a.s. comunica che in data 22 aprile 2026 è entrata in vigore la transazione in seguito alla quale Gevorkyan Sinteris Italia S.r.l. ha acquisito tutte le attività dello stabilimento italiano...
-
Společnost GEVORKYAN, a.s. tímto informuje, že ke dni 22. dubna 2026 nabyla účinnosti transakce, v jejímž důsledku se společnost stala 100% vlastníkem společnosti Gevorkyan Sinteris Italia S.r.l. se...
-
GEVORKYAN, a.s. hereby informs that, as of April 22, 2026, the transaction became effective, as a result of which the company became the 100% owner of Gevorkyan Sinteris Italia S.r.l., based in...
-
2026 m. balandžio 21 d. tarptautinė reitingų agentūra „Moody‘s Ratings“ („Moody’s“) padidino AB Artea banko ilgalaikių indėlių reitingą nuo Baa1 iki A3 ir pakeitė perspektyvą iš stabilios į teigiamą....
-
On 21 April 2026, the international rating agency Moody’s Ratings (Moody’s) upgraded AB Artea bankas long-term deposit rating from Baa1 to A3 and revised the outlook from stable to positive. Moody's...
-
Hydros resultat for første kvartal 2026 blir offentliggjort 29. april 2026 kl. 07.00 CEST (01.00 EDT, 06.00 BST, 05.00 UTC/GMT). Kvartalsrapporten og presentasjonsmaterialet blir gjort tilgjengelig...
-
Hydro's first quarter results 2026 will be released at 07:00 CEST (01:00 EDT, 06:00 BST, 05:00 UTC/GMT) on April 29, 2026. The quarterly report and presentation will be available on hydro.com at the...
-
LONDON, 22 Apr. 2026 (GLOBE NEWSWIRE) -- This is the Start of Day Message for GlobeNewswire. GlobeNewswire is operated by Notified and is designated by the FCA as an approved primary information...
-
VANCOUVER, British Columbia, April 21, 2026 (GLOBE NEWSWIRE) -- The National Police Federation (NPF) is condemning the failure of the justice system to provide any meaningful voice to the family of...
-
Late-breaking Phase III FENhance 1 and 2 study results showed superiority of investigational fenebrutinib compared to teriflunomide in reducing relapses and brain lesions in relapsing multiple...